Epidemic

Discussions about the reasonable number of deaths in a pandemic, about whether or not the price for saving people is killing the economy and, ultimately, debates on a life’s value were brought to the fore by the COVID-19 pandemic.

In mid-April 2014, the words 'scandal', 'secret', 'drugs', and 'Roche' (the Swiss drug giant) delighted the medical press, which was quick to publish tantalizing news about the ineffectiveness of Tamiflu and the enormous amounts spent by governments in order to stock up on the drug, in preparation for possible flu epidemics.

Who do we listen to? Who is right? Who is balanced? How should we react to the risk of the new coronavirus?

Tueday, 31 March 2020, marked exactly three months since the World Health Organization, the Chinese office, was notified of incidences of pneumonia from an unknown cause. According to specialists from the Robert Koch Institute in Germany, we have not yet reached the peak of the pandemic in Europe. We hear about mild and asymptomatic cases, but also about many deaths globally.

Noemina is a graduate of the University of Hertfordshire, UK, where she majored in health care. She is working in her field as of 2012. The journal excerpt she sent to us reflects her week-long experience at the epicentre of the battle with the new coronavirus in the intensive care unit, where serious cases are admitted.